Skip to main content

Guideline Updates

NCCN Updates Clinical Practice Guideline for Multiple Myeloma

March 16, 2021

On March 15, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for multiple myeloma.

In the section for therapy for previously treated multiple myeloma, under other regimens, melphalan flufenamide/dexamethasone was added as a category 2A recommendation.—Janelle Bradley

Back to Top